Cipla Share Price
1383.00-11.70 (-0.84%)
-12.38% past 1 Year
Cipla is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The company has its wide network of manufacturing,
Corporate filings & documents
Announcements
Please find enclosed press release titled Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab) in the US
20 hours agoPlease find enclosed press release titled Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab) in the US
20 hours agoPlease find enclosed disclosure
23 hours agoPlease find enclosed disclosure
23 hours agoPlease find attached newspaper publication regarding opening of special window for re-lodgement of transfer and dematerialisation of physical shares
1 day agoPlease find attached newspaper publication regarding opening of special window for re-lodgement of transfer and dematerialisation of physical shares
1 day agoPlease find enclosed press release titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)"
4 days agoPlease find enclosed press release titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)"
4 days agoPlease find enclosed disclosure.
6 days agoPlease find enclosed disclosure.
6 days agoPlease find enclosed disclosure.
1 week agoPlease find enclosed disclosure.
1 week agoPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we herein mention the schedule of Analyst / Institutional Investor Meeting with the Company.
1 week agoPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we herein mention the schedule of Analyst / Institutional Investor Meeting with the Company.
1 week agoIn terms of regulation 30 of SEBI (LODR) Regulations 2015 we hereby notify that the Operations and Admisnistrative Committee of the Company on 26th August 2026 has allotted 5 281 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.
1 week agoIn terms of regulation 30 of SEBI (LODR) Regulations 2015 we hereby notify that the Operations and Admisnistrative Committee of the Company on 26th August 2026 has allotted 5 281 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.
1 week agoPlease find enclosed disclosure
1 week agoPlease find enclosed disclosure
1 week agoCipla has informed the exchange about receipt of order from Honble NCLT Mumbai Bench
2 weeks agoCipla has informed the exchange about receipt of order from Honble NCLT Mumbai Bench
2 weeks agoPlease find attached disclosure on ESG Ratings.
3 weeks agoPlease find attached disclosure on ESG Ratings.
3 weeks agoPlease find enclosed intimation.
1 month agoPlease find enclosed intimation.
1 month agoIn compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 31st July 2026 has allotted 7 850 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Cipla ESOP Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.
1 month agoIn compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 31st July 2026 has allotted 7 850 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Cipla ESOP Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.
1 month agoPlease find enclosed disclosure
1 month agoPlease find enclosed Earnings Call Transcript - Q1FY27
1 month agoPlease find enclosed Earnings Call Transcript - Q1FY27
1 month agoPlease find attached newspaper intimation for unaudited financial results for the quarter ended 30th June 2026.
1 month agoPlease find attached newspaper intimation for unaudited financial results for the quarter ended 30th June 2026.
1 month agoPursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the earnings conference call for Q1FY27 held today is available on the Companys website at https://www.cipla.com/audio/15001.
1 month agoPursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the earnings conference call for Q1FY27 held today is available on the Companys website at https://www.cipla.com/audio/15001.
1 month agoPlease find enclosed disclosure
1 month agoPlease find enclosed disclosure
1 month agoPlease find enclosed disclosure
1 month agoPlease find enclosed disclosure
1 month agoPlease find enclosed disclosure
1 month agoPlease find enclosed disclosure on Regulation 30(5)
1 month agoPlease find enclosed disclosure
1 month agoPlease find enclosed disclosure
1 month agoPlease find enclosed the disclosure relating to the change in SMP.
1 month agoPlease find enclosed the disclosure relating to the change in SMP.
1 month agoPlease find enclosed the disclosure relating to the change in CFO.
1 month agoPlease find enclosed the disclosure relating to the change in CFO.
1 month agoPlease find enclosed outcome of Board meeting.
1 month agoPlease find enclosed outcome of Board meeting.
1 month agoPlease find attached press release for Q1FY27 financial results
1 month agoPlease find attached press release for Q1FY27 financial results
1 month agoPlease find attached Investor Presentation
1 month agoConcalls & investor presentations
Jul 2026
May 2026
Jan 2026
ConcallPresentation
Oct 2025
ConcallPresentation
Jul 2025
May 2025
Jan 2025
Oct 2024
Jul 2024
May 2024
Jan 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Oct 2023
Jul 2023
May 2023
Jan 2023
Nov 2022
Jul 2022
May 2022
Jan 2022
Oct 2021
Aug 2021
May 2021
Jan 2021
Nov 2020
Corporate Actions
Date
Type
Details
2026-06-05
Dividend
13.0
2025-06-27
Dividend
3.0
2025-06-27
Dividend
13.0
2024-08-02
Dividend
13.0
2023-07-21
Dividend
8.5
2022-08-08
Dividend
5.0
2021-08-09
Dividend
5.0
2020-03-19
Dividend
4.0
2018-08-13
Dividend
3.0
2017-07-26
Dividend
2.0
2016-09-12
Dividend
2.0
2015-08-11
Dividend
2.0
2014-08-06
Dividend
2.0
2013-08-06
Dividend
2.0
2012-08-01
Dividend
2.0
2011-08-09
Dividend
2.0
2010-09-03
Dividend
0.8
2010-07-23
Dividend
2.0
Company details
Registered office
Cipla House, Peninsula Business Park Ganpatrao Kadam Marg Lower Parel Mumbai Maharashtra PIN: 400013 Tel No: 022-24826000 / 41916000 Fax No: 022-24826120 Email: [email protected] / [email protected] Internet: www.cipla.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Y K Hamied, Chairman
P R Ramesh, Vice Chairman
Abhijit Joshi, Non Executive Director
Adil Zainulbhai, Non Executive Director
Kamil Hamied, Non Executive Director
Balram Bhargava, Non Executive Independent Director
Maya Hari, Non Executive Independent Director
Sharmila Paranjpe, Non Executive Independent Director
Achin Gupta, Managing Director & Global Chief Executive Officer
Rajendra Chopra, Company Secretary & Compliance Officer
Mandar Purushottam Vaidya, Non Executive Independent Director
Details
BSE 500087
NSE CIPLA
ISIN INE059A01026